Illumina, Inc. vs Koninklijke Philips NV — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Koninklijke Philips NV trades at $26.99 (market cap $26.58B). The key difference: Illumina, Inc. and Koninklijke Philips NV are close in size by market cap, and Koninklijke Philips NV pays a 3.75% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | PHG | |
|---|---|---|
Market Cap | $29.12B | $26.58B |
Sector | Health | Health |
52-Week High | $205.10 | $32.91 |
52-Week Low | $91.00 | $25.02 |
Enterprise Value | $30.48B | $33.13B |
Dividend Yield | — | 3.75% |
Trailing returns across standard periods
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →